RESEARCH SPOTLIGHT
New report finds disruption to Australian ecstasy market following COVID-19 restrictions
The Drug Trends program at the National Drug and Alcohol Research Centre (NDARC), UNSW Sydney has found evidence of ongoing disruption to Australian ecstasy markets since COVID-19 and associated restrictions.
Key findings from the 2022 Ecstasy and Related Drugs Reporting System (EDRS) interviews with people who regularly use ecstasy and other illicit stimulants highlight significant changes in the perceived availability of all forms of ecstasy, with more participants nominating availability as ‘difficult’ or ‘very difficult’ relative to 2021 and prior.
